Viwit Pharma, established in 2006 supports drug development from proof of concept to commercialization with US FDA, EU, Health Canada, Mexico Cofepris and CFDA approved manufacturing sites for API with state of the art R&D platform. We also have solid orals and injectables facility for formulations. Viwit has two integrated R&D centers and three cGMP production facilities. It covers a land area of 199,000 ㎡ and employs nearly 600 staffs, including more than 150 scientists, many with PhD or master’s degrees.